Search clinical trials for: Propoxyphene napsylate (XP20C)

Total 33 results

Xanodyne Pharmaceuticals

Terminated

Multiple-Ascending-Dose Study to Evaluate the Safety of Propoxyphene Napsylate In Healthy Adult Subjects

Healthy

United States
BTL Industries Ltd.

Completed

Safety and Efficacy of XP200 Radiofrequency Treatment of Wrinkles

Periorbital Wrinkles
Xanodyne Pharmaceuticals

Completed

Efficacy of XP20B Following Bunionectomy Surgery

Acute Pain

United States
Meridian Bioscience, Inc.

Completed

Determination of HCC With Octanoate Breath Test vs. MRI Diagnosis

Hepatocellular Carcinoma (HCC)

China
Grifols Therapeutics LLC

Completed

Safety and Pharmacokinetics of IGSC 20% in Subjects With Primary Immunodeficiency

Primary Immunodeficiency

United States, Canada
Grifols Therapeutics LLC

Completed

An Open-label, Single-Arm Study to Evaluate the Safety and Rabies Virus Antibody Titers of Intramuscularly Administered Rabies Immune Globulin (Human)

Rabies

United States
Vanderbilt University

Active, not recruiting

Reduction in Splanchnic Capacitance Contributes to Sympathetically Dependent Hypertension in Autonomic

Multiple System Atrophy | Orthostatic Hypotension | Supine Hypertension

United States
zr Pharma & GmbH

Completed

Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor

Neoplasms

United Kingdom, Poland, Slovakia
Vanderbilt University

Active, not recruiting

Role of Sympathetic Activity and Splanchnic Capacitance in Hypertension

Hypertension

United States
Grifols Therapeutics LLC

Completed

Efficacy, Pharmacokinetics, Safety, and Tolerability of IGSC 20% in Subjects With Primary Immunodeficiency

Primary Immunodeficiency

Spain, France, Germany, United Kingdom, Australia, Czechia, Hungary, Poland, Sweden
pharmaand GmbH

Terminated

A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes (LODESTAR)

Solid Tumor

United States
Grifols Therapeutics LLC

Completed

A Study to Evaluate IGSC 20% Biweekly Dosing in Treatment-Experienced Participants and Loading/Maintenance Dosing in Treatment-Naïve Participants With Primary Immunodeficiency

Primary Immunodeficiency

United States
Beth Israel Deaconess Medical Center
Grifols Biologicals, LLC

Terminated

The Efficacy Of Intravenous Immunoglobulin Therapy In Treatment Induced Neuropathy Of Diabetes

Diabetes Mellitus | Diabetes Complications | Diabetic Neuropathies

United States
Vanderbilt University

Terminated

Cardiovascular Effects of Angiotensin (1-7) in Essential Hypertension

Hypertension | Hypertension, Essential

United States
Vanderbilt University Medical Center

Withdrawn

Autonomic Blockade and Endogenous Glucose Production

Insulin Resistance

United States
Vanderbilt University Medical Center
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Pathophysiology of Cardiometabolic Risk Factors in African Americans

Hypertension | Obesity

United States
Vanderbilt University

Completed

Nitric Oxide and the Autonomic Nervous System

Hypertension | Pure Autonomic Failure

United States
University of Rochester
Endo Pharmaceuticals

Terminated

Lumbar Stenosis Outcomes Research II (LUSTORII)

Lumbar Spinal Stenosis

United States
Grifols Therapeutics LLC

Completed

Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients

Common Variable Immunodeficiency | Severe Combined Immunodeficiency | Wiskott-Aldrich Syndrome | Agammaglobulinemia | Immunologic Deficiency Syndrome

Canada, United States
Vanderbilt University

Completed

Autonomic Nervous System and Nitric Oxide Interactions

Endothelial Dysfunction

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Active, not recruiting

A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy (CASPAR)

Castration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
Hanmi Pharmaceutical Company Limited

Completed

Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension

Hypertension

Korea, Republic of
Vanderbilt University

Completed

Autonomic Nervous System and Chronic Fatigue Syndrome (CFS&ANS)

Chronic Fatigue Syndrome | Orthostatic Intolerance | Postural Tachycardia Syndrome

United States
Vanderbilt University

Completed

The Autonomic Nervous System and Obesity

OBESITY | HYPERTENSION | PURE AUTONOMIC FAILURE | SHY-DRAGER SYNDROME

United States
Hanmi Pharmaceutical Company Limited

Completed

An Observational Study to Evaluate Effectiveness and Safety of Amosartan Plus Tablet

Hypertension,Essential

Korea, Republic of
Organon and Co

Completed

Efficacy of Losartan + Amlodipine Compared to Amlodipine Alone in the Treatment of Uncontrolled High Blood Pressure (MK-0954F-399)

Hypertension
Grifols Therapeutics LLC

Completed

Rapid Infusion Of Immune Globulin Intravenous (IGIV) In Patients With ITP

Purpura, Thrombocytopenic, Idiopathic

United States
Ohio State University Comprehensive Cancer Center
ImmunoGen, Inc.; Clovis Oncology, Inc.

Active, not recruiting

Mirvetuximab Soravtansine and Rucaparib Camsylate in Treating Participants With Recurrent Endometrial, Ovarian, Fallopian Tube or Primary Peritoneal Cancer

BRCA1 Gene Mutation | BRCA2 Gene Mutation | Folate Receptor Alpha Positive | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Recurrent Uterine Serous Carcinoma | Recurrent Uterine Carcinosarcoma | Platinum...

United States
University of Washington

Active, not recruiting

Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency

BRCA1 Gene Mutation | BRCA2 Gene Mutation | Castration-Resistant Prostate Carcinoma | Homologous Recombination Deficiency | PSA Progression | Stage IV Prostate Adenocarcinoma AJCC v7 | Castration Levels of Testosterone | ATM Gene Mutation | Prostate Carcinoma Metastatic in the Bone | PSA Level Greater...

United States
Grifols Therapeutics LLC

Completed

Immune Globulin Intravenous (IGIV) For Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (ICE)

Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

United States, Israel, Germany, Czech Republic, Mexico, Argentina, Canada, Italy, Poland, Serbia
zr Pharma & GmbH

Completed

Pharmacokinetic Drug-Drug Interaction Study of Rucaparib (DDI)

Neoplasms

Poland
Grifols Therapeutics LLC

Completed

Use of Immune Globulin Intravenous (Human) To Treat Age-Related Macular Degeneration

Macular Degeneration

Germany
Grifols Therapeutics LLC

Completed

Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis (PRIVIG)

Multiple Sclerosis, Relapsing-Remitting

Canada, Israel, United States, Austria, Czech Republic, Germany, Greece, Hungary, Poland, Slovakia, Sweden, United Kingdom

Search clinical trials for: Propoxyphene napsylate (XP20C)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations